The "Ophthalmology Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.
The global ophthalmology drugs market is expected to reach around $33 billion in 2020.
The ophthalmology drugs market covers drugs that are used in the treatment of eye related diseases such as refractive errors, cataracts, glaucoma, conjunctivitis, retinal diseases, and macular degeneration. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azop
RelSci News & Alerts gets you: